Sang Youn Hwang (Sangyoun Hwang, Sang-Youn Hwang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Combination Therapy

Metastatic Colorectal Cancer

Lymph Node Metastasis

Top Venues

Journal of liver cancer

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sang Youn Hwang, Hyun Young Woo, Jeong Heo, Hyung Jun Kim, Young Joo Park, Ki Youn Yi, Yu Rim Lee, Soo-Young Park, Woo Jin Chung, Byoung Kuk Jang, Won Young Tak
Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma. Cancers 16 (4) (2024)
Sang Youn Hwang, Hyun Young Woo, Jeong Heo, Hyung Jun Kim, Young Joo Park, Ki Youn Yi, Yu Rim Lee, Soo-Young Park, Woo Jin Chung, Byoung Kuk Jang, Won Young Tak
Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma. Cancers 16 (4) (2024)
Hongqun Liu, Dae-Gon Ryu, Sang Youn Hwang, Samuel S Lee
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities. International journal of molecular sciences 25 (11) (2024)
Hongqun Liu, Dae-Gon Ryu, Sang Youn Hwang, Samuel S Lee
Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities. International journal of molecular sciences 25 (11) (2024)
Hyung Jun Kim, Sang Youn Hwang, Jeong Woo Lim, Ki Jeong Jeon, Wan Jeon
A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab. Journal of liver cancer 23 (1) (2023)
Sang Youn Hwang, Hongqun Liu, Samuel S Lee
Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy. Biomedicines 11 (7) (2023)
Hyung Jun Kim, Sang Youn Hwang, Jeong Woo Lim, Ki Jeong Jeon, Wan Jeon
A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab. Journal of liver cancer 23 (1) (2023)
Hongqun Liu, Henry H Nguyen, Sang Youn Hwang, Samuel S Lee
Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension. International journal of molecular sciences 24 (23) (2023)
Hyung Jun Kim, Sang Youn Hwang, Jeong Woo Lim, Ki Jeong Jeon, Wan Jeon
A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab. Journal of liver cancer 23 (1) (2023)
Hongqun Liu, Sang Youn Hwang, Samuel S Lee
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Hyung Jun Kim, Sang Youn Hwang, Jeong Woo Lim, Ki Jeong Jeon, Wan Jeon
A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab. Journal of liver cancer 23 (1) (2023)
Sang Youn Hwang, Sun Mi Lee, Jeong Woo Lim, Ki Jeong Jeon, Hye Won Lee
Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report. Journal of liver cancer 21 (2) (2021)
Sang Youn Hwang, Sun Mi Lee, Jeong Woo Lim, Ki Jeong Jeon, Hye Won Lee
Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report. Journal of liver cancer 21 (2) (2021)
Sang Youn Hwang, Sun Mi Lee, Jeong Woo Lim, Ki Jeong Jeon, Hye Won Lee
Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report. Journal of liver cancer 21 (2) (2021)
Sang Youn Hwang, Sun Mi Lee, Jeong Woo Lim, Ki Jeong Jeon, Hye Won Lee
Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report. Journal of liver cancer 21 (2) (2021)